Mitochondrial Dysfunction as a Therapeutic Target in Diabetic Cardiomyopathy: Progress and Prospects
Diabetic cardiomyopathy (DCM) is a specific type of cardiomyopathy that is independent of hypertension and coronary artery disease, and is closely associated with the high incidence and mortality of heart failure in people with diabetes. DCM causes microvascular disease, myocardial metabolic disorde...
Saved in:
Main Authors: | Feng Zhang, Zhuqing Li, Yanxin Wang, Chao Li, Chengzhi Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Compuscript Ltd
2025-01-01
|
Series: | Cardiovascular Innovations and Applications |
Online Access: | https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2024.0063 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mitochondrial Dysfunction and Therapeutic Targets in Auditory Neuropathy
by: Baoyi Feng, et al.
Published: (2020-01-01) -
Mitochondrial Dysfunction and Diabetic Nephropathy: Nontraditional Therapeutic Opportunities
by: Ping Na Zhang, et al.
Published: (2021-01-01) -
Mitochondrial Dysfunction in Diabetic Periodontitis: Mechanisms and Therapeutic Potential
by: Meng L, et al.
Published: (2025-01-01) -
Diabetic Cardiomyopathy: Current Approach and Potential Diagnostic and Therapeutic Targets
by: Georgiana-Emmanuela Gilca, et al.
Published: (2017-01-01) -
Impaired Iron–Sulfur Cluster Synthesis Induces Mitochondrial PARthanatos in Diabetic Cardiomyopathy
by: Mengyi Wang, et al.
Published: (2025-01-01)